ATE223056T1 - Diagnose von neuro-degenerativen erkrankungen - Google Patents

Diagnose von neuro-degenerativen erkrankungen

Info

Publication number
ATE223056T1
ATE223056T1 AT98300342T AT98300342T ATE223056T1 AT E223056 T1 ATE223056 T1 AT E223056T1 AT 98300342 T AT98300342 T AT 98300342T AT 98300342 T AT98300342 T AT 98300342T AT E223056 T1 ATE223056 T1 AT E223056T1
Authority
AT
Austria
Prior art keywords
neuro
diagnosis
degenerative diseases
sample
particulate material
Prior art date
Application number
AT98300342T
Other languages
English (en)
Inventor
Harash Kumar Narang
Original Assignee
Biotec Global Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotec Global Ltd filed Critical Biotec Global Ltd
Application granted granted Critical
Publication of ATE223056T1 publication Critical patent/ATE223056T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT98300342T 1997-01-18 1998-01-19 Diagnose von neuro-degenerativen erkrankungen ATE223056T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9701045.8A GB9701045D0 (en) 1997-01-18 1997-01-18 Diagnosis of neuro-degenerative disorders

Publications (1)

Publication Number Publication Date
ATE223056T1 true ATE223056T1 (de) 2002-09-15

Family

ID=10806230

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98300342T ATE223056T1 (de) 1997-01-18 1998-01-19 Diagnose von neuro-degenerativen erkrankungen

Country Status (7)

Country Link
EP (1) EP0854364B1 (de)
AT (1) ATE223056T1 (de)
DE (1) DE69807363T2 (de)
DK (1) DK0854364T3 (de)
ES (1) ES2185111T3 (de)
GB (1) GB9701045D0 (de)
PT (1) PT854364E (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999006838A2 (en) * 1997-08-01 1999-02-11 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Novel method of detecting amyloid-like fibrils or protein aggregates
WO1999006545A2 (en) 1997-08-01 1999-02-11 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation
AU755535B2 (en) * 1998-02-06 2002-12-12 Harash Kumar Narang Diagnosis of neuro-degenerative disorders
US7595199B1 (en) 1998-07-31 2009-09-29 Max-Planck-Gesellschaft zur Förderung der Wissenchaften e.V. Method of detecting amyloid-like fibrils or protein aggregates
IL141950A0 (en) * 2000-10-22 2002-03-10 Hadasit Med Res Service Diagnosis of prion diseases
DE10061200A1 (de) * 2000-12-08 2002-06-27 Niels Wedemeyer Verfahren und Kit zur Diagnose spongiformer Encephalopathien
WO2005010533A2 (en) * 2003-07-31 2005-02-03 Hadasit Medical Research Services & Development Ltd. Methods and kits for the detection of prion diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234814A (en) * 1989-06-01 1993-08-10 Du Pont Merck Pharmaceutical Company Diagnostic assay for alzheimer's disease
JPH0327349A (ja) * 1989-06-24 1991-02-05 Asahi Optical Co Ltd 蛋白質、ペプチド及びアミノ酸の分離方法
WO1993003369A1 (en) * 1991-08-01 1993-02-18 Voorheis Paul H Diagnostic method for alzheimer's disease
GB9117910D0 (en) * 1991-08-20 1991-10-09 Nat Res Dev Oligonucleotides and their use in an assay
FI972254A7 (fi) * 1994-11-29 1997-07-28 The Mini Of Agriculture Sienimuotoisen aivosairauden defektiomenetelmät
EP0795132A1 (de) * 1994-11-29 1997-09-17 The Minister Of Agriculture Fisheries And Food In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain Spongiforme encephalopathie nachweissverfahren

Also Published As

Publication number Publication date
EP0854364B1 (de) 2002-08-28
DK0854364T3 (da) 2002-12-23
DE69807363T2 (de) 2003-04-30
ES2185111T3 (es) 2003-04-16
PT854364E (pt) 2003-01-31
EP0854364A1 (de) 1998-07-22
GB9701045D0 (en) 1997-03-05
DE69807363D1 (de) 2002-10-02

Similar Documents

Publication Publication Date Title
DE3685344D1 (de) Vorrichtung zur feststellung von okkultem blut.
ES2061873T3 (es) Enriquecimiento y concentracion de proteinas por ultrafiltracion.
ATE180261T1 (de) Durch menschliche lymphozyten produzierte proteine, die für diese proteine kodierende dns und pharmazeutische und biologische verwendungen
LU91015I2 (fr) Recombinate (Rurioctocog alfa) dans toutes ses formes couvertes par le brevet de base
ATE315654T1 (de) Diagnose und behandlung von mit aur-1 und/oder aur-2 assoziierten erkrankungen
DE69838389D1 (de) Regeneration von biosensoren
DE3675702D1 (de) Vorrichtung zum erfassen von fremden substanzen durch eine trennwand und fahrhilfssystem fuer fahrzeuge oder luftfahrzeuge.
DE69334246D1 (de) Verbesserte reagentien und methoden zur diagnose und behandlung von diabetes und stiff man syndrome
ATE366812T1 (de) Neue methode zur erkennung eines stoffes, der die interaktion zwischen einem tnf-liganden und seinem rezeptor auf b-zellen moduliert
DE68919446D1 (de) Vorrichtung zum Sammeln von Blutproben.
DE3765138D1 (de) Mehrschichtiges element zur quantitativen analyse von immunoreagenzien.
DE3769808D1 (de) Vorrichtung zur ueberwachung von okkultem blut.
ATE271603T1 (de) Identifizierungsverfahren für substanzen die an das pyk2 polypeptid binden
DE59101912D1 (de) Vorrichtung zur Analyse von Druckkontrollfeldern.
DE69807363D1 (de) Diagnose von neuro-degenerativen Erkrankungen
FR2625321B1 (fr) Reactif pour le diagnostic de staphylococcus aureus par agglutination
PT1105508E (pt) Metodo de purificacao de complexos de biomoleculas ou de proteinas
DE3587542D1 (de) Verfahren zur Diagnose in vitro von menschlichen Cytomegalovirusinfektionen und Anwendung von monoklonalen Antikörpern gegen Cytomegaloviren, die mit einer cytomegalovirusinduzierten Proteinkinase reagieren.
DE69020987D1 (de) Verfahren und Vorrichtung zur elektrochemischen Analyse und wässerige Lösung zur Durchführung der Analyse.
SE7704359L (sv) Forfarande for anrikning av ett placentaspecifikt glykoprotein
IT8423926A0 (it) Metodo diagnostico per la valutazione di parametri clinici mediante prelievo diretto dimateriali biologici e dispositivoper la sua attuazione.
ATE22651T1 (de) Verfahren zum reinigen bzw. anreichern von biologisch aktiven proteinen und hierzu geeignetes mittel.
NO903681D0 (no) Monoklonale antistoffer mot aktiverte ras-proteiner med aminosyremutasjoner i posisjon 13 i proteinet.
DE69327167D1 (de) Nukleotidsequenzen die fur proteine von cryptosporidium kodieren, polypeptide, welche durch diese sequenzen kodiert werden, und kits fur deren benutzung
CA2286279A1 (en) Diagnosis of neuro-degenerative disorders

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties